We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Mapping Human Proteins Will Help Identify Diseases

By LabMedica International staff writers
Posted on 27 Oct 2008
Swedish scientists are creating an atlas of the proteins in the human's body tissues and cells. More...
The atlas should enlighten scientists about the function of the proteins and how changes in their distribution could be reflected in certain diseases such as cancer.

The protein atlas team uses the human genome to encode individual proteins. Antibodies are then developed against each of these proteins. The antibody that recognizes a given protein is then labeled with a marker to render it visible under a microscope and is exposed to samples of different tissues and cells. The antibody binds to the proteins and in this way, the location of the protein can be detected.

Functional genomics describes the way in which genes and their products, proteins, interact together in complex networks in living cells. Professor Mathias Uhlén of the Royal Institute of Technology (KTH; Stockholm, Sweden), who is leading the project, described the human protein atlas at the European Science Foundation's Third Functional Genomics Conference in Innsbruck, Austria, on October 1-4, 2008.

The protein atlas project is a very ambitious. "To do this systematically requires a lot of automation and robotics," Professor Uhlén said. "We have six software engineers writing codes just to keep track of the samples. The project is generating 400 gigabytes of data every day." There is a 100-strong team working on the project, with a site due to be set up soon in India, and with antibody-producing sites in Korea and China.

The team has so far mapped the location of around 5000 proteins in human cells and tissues. The scientists are investigating whether certain common cancers--colon, prostate, lung, and breast--have different protein profiles to normal tissue. In this way, new biomarkers can be identified, which could alert doctors to the early stages of a disease.

Related Links:
Royal Institute of Technology



Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Clinical Chemistry System
P780
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more

Pathology

view channel
Image: The AI tool advances precision diagnostics by linking genetic mutations directly to disease types (Photo courtesy of Shutterstock)

AI Tool Simultaneously Identifies Genetic Mutations and Disease Type

Interpreting genetic test results remains a major challenge in modern medicine, particularly for rare and complex diseases. While existing tools can indicate whether a genetic mutation is harmful, they... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.